| pubmed-article:17394942 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C0007113 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C0445204 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C1512814 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:17394942 | lifeskim:mentions | umls-concept:C1511253 | lld:lifeskim |
| pubmed-article:17394942 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17394942 | pubmed:dateCreated | 2007-3-30 | lld:pubmed |
| pubmed-article:17394942 | pubmed:abstractText | To determine the safety and efficacy of preoperative hypofractionated radiotherapy using intensity-modulated radiotherapy (IMRT) and an incorporated boost with concurrent capecitabine in patients with locally advanced rectal cancer. | lld:pubmed |
| pubmed-article:17394942 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17394942 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17394942 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17394942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17394942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17394942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17394942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17394942 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17394942 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17394942 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:StanT CTC | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:HoffmanJohnJ | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:MeropolNeal... | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:SigurdsonElin... | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:PriceRobertR | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:ChengJonathan... | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:RogatkoAndréA | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:Watkins-Brune... | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:FreedmanGary... | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:KonskiAndreA | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:CallahanElain... | lld:pubmed |
| pubmed-article:17394942 | pubmed:author | pubmed-author:CohenSteveS | lld:pubmed |
| pubmed-article:17394942 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17394942 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17394942 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:17394942 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17394942 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17394942 | pubmed:pagination | 1389-93 | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:meshHeading | pubmed-meshheading:17394942... | lld:pubmed |
| pubmed-article:17394942 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17394942 | pubmed:articleTitle | Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. | lld:pubmed |
| pubmed-article:17394942 | pubmed:affiliation | Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19111, USA. G_Freedman@FCCC.edu | lld:pubmed |
| pubmed-article:17394942 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17394942 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17394942 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17394942 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17394942 | lld:pubmed |
